Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8902 |
High Similarity |
NPD3818 |
Discontinued |
0.8864 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8644 |
High Similarity |
NPD6797 |
Phase 2 |
0.8596 |
High Similarity |
NPD7251 |
Discontinued |
0.8547 |
High Similarity |
NPD7808 |
Phase 3 |
0.8483 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8483 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8427 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8409 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8391 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8382 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8382 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8371 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8333 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8295 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8276 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8276 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8276 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8258 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8258 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8258 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8232 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8218 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8208 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8207 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8161 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8125 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8122 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8103 |
Intermediate Similarity |
NPD37 |
Approved |
0.8087 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8066 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.8057 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8045 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8022 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8011 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7989 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7989 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7955 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7955 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7933 |
Intermediate Similarity |
NPD5494 |
Approved |
0.791 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7903 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7903 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7898 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7874 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7872 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7861 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7853 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7845 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7816 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7766 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7746 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7746 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7733 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7722 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7714 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7684 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7644 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7614 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7614 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7614 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7614 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7614 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7614 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7609 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7604 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7582 |
Intermediate Similarity |
NPD919 |
Approved |
0.7574 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7563 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7558 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7542 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7537 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7537 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2534 |
Approved |
0.75 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2532 |
Approved |
0.75 |
Intermediate Similarity |
NPD1247 |
Approved |
0.75 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7680 |
Approved |
0.75 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7471 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7463 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7463 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7457 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7413 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7413 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7405 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7396 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.738 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7376 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7371 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7363 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.736 |
Intermediate Similarity |
NPD6534 |
Approved |
0.736 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7358 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7353 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD3226 |
Approved |
0.733 |
Intermediate Similarity |
NPD7801 |
Approved |
0.733 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.733 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7299 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7277 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7277 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.725 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7225 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7209 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7207 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7207 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7189 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7184 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7183 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7164 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7151 |
Intermediate Similarity |
NPD943 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7112 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7108 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.709 |
Intermediate Similarity |
NPD5710 |
Approved |
0.709 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.709 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7079 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7053 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7052 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7052 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7052 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7045 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7035 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7033 |
Intermediate Similarity |
NPD920 |
Approved |
0.703 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7022 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7017 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.701 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7009 |
Intermediate Similarity |
NPD4111 |
Phase 1 |
0.7009 |
Intermediate Similarity |
NPD4665 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD7296 |
Approved |
0.6995 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6989 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6971 |
Remote Similarity |
NPD7583 |
Approved |
0.6971 |
Remote Similarity |
NPD1607 |
Approved |
0.6963 |
Remote Similarity |
NPD5242 |
Approved |
0.6957 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6952 |
Remote Similarity |
NPD5353 |
Approved |
0.6949 |
Remote Similarity |
NPD6099 |
Approved |
0.6949 |
Remote Similarity |
NPD6100 |
Approved |
0.6944 |
Remote Similarity |
NPD8366 |
Approved |
0.6944 |
Remote Similarity |
NPD7907 |
Approved |
0.6943 |
Remote Similarity |
NPD7799 |
Discontinued |
0.6936 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6927 |
Remote Similarity |
NPD2403 |
Approved |
0.6927 |
Remote Similarity |
NPD2800 |
Approved |
0.691 |
Remote Similarity |
NPD2344 |
Approved |
0.6908 |
Remote Similarity |
NPD4004 |
Approved |
0.6908 |
Remote Similarity |
NPD4002 |
Approved |
0.6906 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.69 |
Remote Similarity |
NPD4287 |
Approved |
0.6898 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6898 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6895 |
Remote Similarity |
NPD8491 |
Approved |
0.6893 |
Remote Similarity |
NPD3452 |
Approved |
0.6893 |
Remote Similarity |
NPD2493 |
Approved |
0.6893 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6893 |
Remote Similarity |
NPD2494 |
Approved |
0.6893 |
Remote Similarity |
NPD3450 |
Approved |
0.6888 |
Remote Similarity |
NPD6764 |
Approved |
0.6888 |
Remote Similarity |
NPD6765 |
Approved |
0.6885 |
Remote Similarity |
NPD6273 |
Approved |
0.6881 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6881 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6881 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD4582 |
Approved |
0.6875 |
Remote Similarity |
NPD4583 |
Approved |
0.6869
|
Remote Similarity |
NPD8407 |
Phase 2 |